p16 Rabbit Polyclonal Antibody
To Order Contact us: [email protected]
Rabbit Polyclonal p16 INK Antibody |
|||
TA325354 | Origene Technologies GmbH | 100 µl | Ask for price |
p16 (phospho Ser326) Rabbit Polyclonal Antibody |
|||
ES4456-100ul | ELK Biotech | 100ul | EUR 124 |
Description: A Rabbit Polyclonal antibody against p16 (phospho Ser326) from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
p16 (phospho Ser326) Rabbit Polyclonal Antibody |
|||
ES4456-50ul | ELK Biotech | 50ul | EUR 74 |
Description: A Rabbit Polyclonal antibody against p16 (phospho Ser326) from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Rabbit anti-P16 Polyclonal Antibody |
|||
TA326805 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit polyclonal p16-INK4a (Phospho-Ser152) antibody |
|||
TA326052 | Origene Technologies GmbH | 100 µl | Ask for price |
p16 Polyclonal Antibody |
|||
ABP52099-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of p16 from Human, Mouse. This p16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human p16 at AA range: 10-90 |
p16 Polyclonal Antibody |
|||
ABP52099-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of p16 from Human, Mouse. This p16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human p16 at AA range: 10-90 |
p16 Polyclonal Antibody |
|||
ABP52099-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of p16 from Human, Mouse. This p16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human p16 at AA range: 10-90 |
p16 Polyclonal Antibody |
|||
ABP52099-100uL | Abbkine | 100 μL | EUR 239 |
Description: Rabbit Anti-p16 Polyclonal Antibody |
p16 Polyclonal Antibody |
|||
ABP52099-200uL | Abbkine | 200 μL | EUR 379 |
Description: Rabbit Anti-p16 Polyclonal Antibody |
p16 Polyclonal Antibody |
|||
ABP52099-30uL | Abbkine | 30 μL | EUR 109 |
Description: Rabbit Anti-p16 Polyclonal Antibody |
p16 Polyclonal Antibody |
|||
ABP57356-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of p16 from Human. This p16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p16 around the non-phosphorylation site of S326 |
p16 Polyclonal Antibody |
|||
ABP57356-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of p16 from Human. This p16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p16 around the non-phosphorylation site of S326 |
p16 Polyclonal Antibody |
|||
ABP57356-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of p16 from Human. This p16 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human p16 around the non-phosphorylation site of S326 |
p16 Polyclonal Antibody |
|||
41296 | SAB | 100ul | EUR 319 |
p16 Polyclonal Antibody |
|||
41296-100ul | SAB | 100ul | EUR 302.4 |
p16 Polyclonal Antibody |
|||
41296-50ul | SAB | 50ul | EUR 224.4 |
p16 Polyclonal Antibody |
|||
E041296 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
p16 Polyclonal Antibody |
|||
E20-75664 | EnoGene | 100ug | EUR 225 |
Description: Available in various conjugation types. |
p16 Polyclonal Antibody |
|||
E20-73493 | EnoGene | 100ug | EUR 225 |
Description: Available in various conjugation types. |
p16 Polyclonal Antibody |
|||
E-AB-13142-120uL | Elabscience Biotech | 120uL | EUR 240 |
Description: Unconjugated |
p16 Polyclonal Antibody |
|||
E-AB-13142-200uL | Elabscience Biotech | 200uL | EUR 399 |
Description: Unconjugated |
p16 Polyclonal Antibody |
|||
E-AB-13142-20uL | Elabscience Biotech | 20uL | EUR 73 |
Description: Unconjugated |
p16 Polyclonal Antibody |
|||
E-AB-13142-60uL | Elabscience Biotech | 60uL | EUR 143 |
Description: Unconjugated |
p16 Polyclonal Antibody |
|||
BT-AP06744-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
Description: CDKN2A (cyclin dependent kinase inhibitor 2A) generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. |
p16 Polyclonal Antibody |
|||
BT-AP06744-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
Description: CDKN2A (cyclin dependent kinase inhibitor 2A) generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. |
p16 Polyclonal Antibody |
|||
BT-AP06744-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
Description: CDKN2A (cyclin dependent kinase inhibitor 2A) generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. |
p16 Polyclonal Antibody |
|||
BT-AP06745-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
Description: CDKN2A (cyclin dependent kinase inhibitor 2A) generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. |
p16 Polyclonal Antibody |
|||
BT-AP06745-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
Description: CDKN2A (cyclin dependent kinase inhibitor 2A) generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. |
p16 Polyclonal Antibody |
|||
BT-AP06745-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
Description: CDKN2A (cyclin dependent kinase inhibitor 2A) generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. CDKN2A is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. |
p16 Polyclonal Antibody |
|||
E44H07106 | EnoGene | 100ul | EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |